In one of the largest studies of its kind, a multinational team led by scientists from deCODE genetics has reported the discovery of common variations at seven new sites in the human genome found to influence obesity. The study analyzed more than 300,000 single-letter variations (SNPs) across the genome of more than 30,000 people from
Full Post: Discovery of seven new sites in the human genome found to influence obesity
Current research suggests laminin, a protein that helps cells stick together, may lead to enhanced muscle repair in muscular dystrophy.
The related report by Rooney et al, “Laminin-111 restores regenerative capacity in a mouse model for alpha 7 integrin congenital myopathy,” appears in the January 2009 issue of The American Journal of Pathology.
Muscular dystrophy is a group of inherited genetic diseases that cause progressive muscle weakness. In one type of muscular dystrophy, patients with mutations in the adhesion molecule alpha 7 integrin experience delayed developmental milestones and impaired mobility. There is currently no treatment or cure for alpha 7 integrin congenital myopathy.
Interactions of alpha 7 integrin with laminin, an extracellular protein found surrounding muscle fibers, promote muscle cell health and survival. Alpha 7 integrin has also been implicated in muscle repair. To determine if alpha 7 integrin is critical for muscle repair, researchers led by Dr. Dean Burkin at The University of Nevada School of Medicine examined the response to muscle damage in alpha 7 integrin-deficient mice. They found that alpha 7 integrin-deficient muscle exhibited defective muscular regeneration. Injection of laminin-111, however, restored muscle repair and regeneration.
The data from Rooney et al “indicate a critical role for the alpha7beta1 integrin and laminin in muscle repair and suggest direct muscle injections of laminin may serve as an exciting novel therapy for patients with alpha 7 integrin congenital myopathy and other muscle diseases.” Dr. Burkin’s group is “currently investigating the potential of this technology to treat Duchenne and other forms of muscular dystrophy. This work opens a whole new modality in therapeutics, of injecting extracellular matrix proteins to treat genetic diseases.”
http://ajp.amjpathol.org/
--------------------------------------------------------------------------------------------
Related Posts:
Mutations in the nuclear intermediate filament lamin A/C (LMNA) gene are associated with Emery-Dreifuss muscular dystrophy, but cause the disease by unknown mechanisms. Méjat et al. show that one mechanism involves the disruption of neuromuscular junctions. The study will appear online on Monday, January 5, 2009 and in the January 12, 2009 print issue of
Full Post: How loss or mutation of LMNA gene causes Emery-Dreifuss muscular dystrophy
Scientists have identified a promising set of new compounds in the fight against muscular dystrophy. Using a drug-discovery technique in which molecules compete against each other for access to the target - the strand of toxic RNA that causes the most common form of muscular dystrophy in adults - a team at the University of
Full Post: Scientists discover new compounds to target muscular dystrophy
A protein that was first identified for playing a key role in regulating normal heart rhythms also appears to be significant in helping muscle cells survive the forces of muscle contraction. The clue was a laboratory mouse that seemed to have a form of muscular dystrophy. A group of proteins called ankyrins, or anchor proteins,
Full Post: Proteins called ankyrins required to prevent muscular dystrophy
The first demonstration that a single adult stem cell can self-renew in a mammal was reported at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco. The transplanted adult stem cell and its differentiated descendants restored lost function to mice with hind limb muscle tissue damage. The adult
Full Post: Single adult stem cell can self-renew in a mammal
Researchers at UMDNJ-Robert Wood Johnson Medical School have identified the protein MG53, as a key initiator of membrane repair in damaged tissue. The study, released in Nature Cell Biology, is the first to specifically pinpoint a protein responsible for promoting cell repair. Led by Jianjie Ma, PhD, professor of physiology and biophysics, the discovery has
Full Post: MG53 protein found to be a key initiator of membrane repair in damaged tissue --------------------------------------------------------------------------------------------
